382 related articles for article (PubMed ID: 25868469)
1. Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording.
Aronsson M; Svennberg E; Rosenqvist M; Engdahl J; Al-Khalili F; Friberg L; Frykman-Kull V; Levin LÅ
Europace; 2015 Jul; 17(7):1023-9. PubMed ID: 25868469
[TBL] [Abstract][Full Text] [Related]
2. A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke.
Levin LÅ; Husberg M; Sobocinski PD; Kull VF; Friberg L; Rosenqvist M; Davidson T
Europace; 2015 Feb; 17(2):207-14. PubMed ID: 25349228
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness and screening performance of ECG handheld machine in a population screening programme: The Belgian Heart Rhythm Week screening programme.
Proietti M; Farcomeni A; Goethals P; Scavee C; Vijgen J; Blankoff I; Vandekerckhove Y; Lip GY; Mairesse GH;
Eur J Prev Cardiol; 2019 Jun; 26(9):964-972. PubMed ID: 30935219
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.
Jacobs MS; Kaasenbrood F; Postma MJ; van Hulst M; Tieleman RG
Europace; 2018 Jan; 20(1):12-18. PubMed ID: 27733465
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.
Lowres N; Neubeck L; Salkeld G; Krass I; McLachlan AJ; Redfern J; Bennett AA; Briffa T; Bauman A; Martinez C; Wallenhorst C; Lau JK; Brieger DB; Sy RW; Freedman SB
Thromb Haemost; 2014 Jun; 111(6):1167-76. PubMed ID: 24687081
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan.
Maeda K; Shimbo T; Fukui T
J Med Screen; 2004; 11(2):97-102. PubMed ID: 15153326
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
Hobbs FD; Fitzmaurice DA; Mant J; Murray E; Jowett S; Bryan S; Raftery J; Davies M; Lip G
Health Technol Assess; 2005 Oct; 9(40):iii-iv, ix-x, 1-74. PubMed ID: 16202350
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Extended and One-Time Screening Versus No Screening for Non-Valvular Atrial Fibrillation in the USA.
Oguz M; Lanitis T; Li X; Wygant G; Singer DE; Friend K; Hlavacek P; Nikolaou A; Mattke S
Appl Health Econ Health Policy; 2020 Aug; 18(4):533-545. PubMed ID: 31849021
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.
Aronsson M; Walfridsson H; Janzon M; Walfridsson U; Nielsen JC; Hansen PS; Johannessen A; Raatikainen P; Hindricks G; Kongstad O; Pehrson S; Englund A; Hartikainen J; Mortensen LS; Levin LÅ
Europace; 2015 Jan; 17(1):48-55. PubMed ID: 25341739
[TBL] [Abstract][Full Text] [Related]
10. Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study.
Svennberg E; Engdahl J; Al-Khalili F; Friberg L; Frykman V; Rosenqvist M
Circulation; 2015 Jun; 131(25):2176-84. PubMed ID: 25910800
[TBL] [Abstract][Full Text] [Related]
11. Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?
Tarride JE; Quinn FR; Blackhouse G; Sandhu RK; Burke N; Gladstone DJ; Ivers NM; Dolovich L; Thornton A; Nakamya J; Ramasundarahettige C; Frydrych PA; Henein S; Ng K; Congdon V; Birtwhistle RV; Ward R; Healey JS
Can J Cardiol; 2018 Nov; 34(11):1522-1525. PubMed ID: 30144961
[TBL] [Abstract][Full Text] [Related]
12. Screening for atrial fibrillation in patients aged 65 years or over attending annual flu vaccination clinics at a single general practice.
Rhys GC; Azhar MF; Foster A
Qual Prim Care; 2013; 21(2):131-40. PubMed ID: 23735694
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in Australia.
Ademi Z; Pasupathi K; Liew D
Eur J Prev Cardiol; 2015 Mar; 22(3):344-53. PubMed ID: 24281250
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study.
Lyth J; Svennberg E; Bernfort L; Aronsson M; Frykman V; Al-Khalili F; Friberg L; Rosenqvist M; Engdahl J; Levin LÅ
Eur Heart J; 2023 Jan; 44(3):196-204. PubMed ID: 36349968
[TBL] [Abstract][Full Text] [Related]
15. Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP).
Friberg L; Engdahl J; Frykman V; Svennberg E; Levin LÅ; Rosenqvist M
Europace; 2013 Jan; 15(1):135-40. PubMed ID: 22791299
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of a specialized atrial fibrillation clinic vs. usual care in patients with atrial fibrillation.
Hendriks J; Tomini F; van Asselt T; Crijns H; Vrijhoef H
Europace; 2013 Aug; 15(8):1128-35. PubMed ID: 23515338
[TBL] [Abstract][Full Text] [Related]
18. Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention.
Engdahl J; Andersson L; Mirskaya M; Rosenqvist M
Circulation; 2013 Feb; 127(8):930-7. PubMed ID: 23343564
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of targeted screening for the identification of patients with atrial fibrillation: evaluation of a machine learning risk prediction algorithm.
Hill NR; Sandler B; Mokgokong R; Lister S; Ward T; Boyce R; Farooqui U; Gordon J
J Med Econ; 2020 Apr; 23(4):386-393. PubMed ID: 31855091
[No Abstract] [Full Text] [Related]
20. Cost-effectiveness of Screening for Atrial Fibrillation Using Wearable Devices.
Chen W; Khurshid S; Singer DE; Atlas SJ; Ashburner JM; Ellinor PT; McManus DD; Lubitz SA; Chhatwal J
JAMA Health Forum; 2022 Aug; 3(8):e222419. PubMed ID: 36003419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
